On April 2, Virpax Pharmaceuticals Inc Got Letter From Nasdaq Stating That Company Was Not In Compliance With Nasdaq Listing Rule
On April 2, Virpax Pharmaceuticals Inc Got Letter From Nasdaq Stating That Company Was Not In Compliance With Nasdaq Listing Rule
4月2日，Virpax Pharmicals Inc收到納斯達克的來信，稱該公司未遵守納斯達克上市規則
On April 2, Virpax Pharmaceuticals Inc Got Letter From Nasdaq Stating That Company Was Not In Compliance With Nasdaq Listing Rule
4月2日，Virpax Pharmicals Inc收到納斯達克的來信，稱該公司未遵守納斯達克上市規則
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。